TechMediaBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Secures Exclusive U.S. Patent for Computer-Aided Diagnosis with Breast CT

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company commercializing imaging-based technologies for improved breast cancer screening, diagnosis, and treatment, announced the issuance of the only U.S. patent for computer-aided diagnosis (CADx) with breast CT, covered under the Company’s exclusive global license agreement with the Regents of the University of California. CADx is an AI software tool that analyzes medical images to estimate malignancy likelihood and support radiologists in interpreting scans. In breast imaging, CADx is being developed to address limitations of mammography, digital breast tomosynthesis, ultrasound, and MRI by detecting subtle abnormalities, improving diagnostic consistency, reducing read times, and streamlining workflows.

To view the full press release, visit https://ibn.fm/VAJQ9

About Izotropic

More information about Izotropic Corporation can be found on its website at izocorp.com and by reviewing its profile on SEDAR at sedarplus.ca

NOTE TO INVESTORS: The latest news and updates relating to IZOZF are available in the company’s newsroom at https://ibn.fm/IZOZF

About TechMediaWire

TechMediaWire (“TMW”) is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, TMW brings its clients unparalleled recognition and brand awareness. TMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Austin, Texas
www.TechMediaWire.com
512.354.7000 Office
Editor@TechMediaWire.com

TechMediaWire is powered by IBN

TechMediaWire

Share
Published by
TechMediaWire

Recent Posts

TechMediaBreaks – Streamex Corp. (NASDAQ: STEX) Sets Second Quarter 2026 Results, Business Update Call 

Streamex (NASDAQ: STEX) announced it will report second-quarter 2026 financial results on Friday, Aug. 14, 2026, and…

3 hours ago

TechMediaBreaks – Wrap Technologies, Inc. (NASDAQ: WRAP) Schedules Second Quarter 2026 Results Call 

Wrap Technologies (NASDAQ: WRAP) announced it will host a conference call on Tuesday, Aug. 11, 2026, at…

3 hours ago

TechMediaBreaks – Why BOXABL Inc. (NASDAQ: BXBL) Is ‘One to Watch’

BOXABL (NASDAQ: BXBL) was featured in a recent article that discussed its positioning as a technology…

3 hours ago

TechMediaBreaks – Gloo Holdings, Inc. (NASDAQ: GLOO) Closes $22.75 Million Public Offering 

Gloo (NASDAQ: GLOO) announced the July 10 closing of its underwritten public offering of 7 million shares…

4 hours ago

TechMediaBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Expands U.S. Federal, Public Safety Operations

This article has been disseminated on behalf of SPARC AI Inc. and may include paid…

6 hours ago

TechMediaBreaks – SRX Global Inc. (NYSE American: SRXH) Acquires Stake in Vistagen Therapeutics 

SRX Global (NYSE American: SRXH) announced that it has acquired a stake in Vistagen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical…

1 day ago